Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases.

Nalli C, Somma V, Andreoli L, Büttner T, Schierack P, Mahler M, Roggenbuck D, Tincani A.

Auto Immun Highlights. 2018 May 29;9(1):6. doi: 10.1007/s13317-018-0106-0.

2.

Generation and validation of murine monoclonal and camelid recombinant single domain antibodies specific for human pancreatic glycoprotein 2.

Schlör A, Holzlöhner P, Listek M, Grieß C, Butze M, Micheel B, Hentschel C, Sowa M, Roggenbuck D, Schierack P, Füner J, Schliebs E, Goihl A, Reinhold D, Hanack K.

N Biotechnol. 2018 Apr 7. pii: S1871-6784(17)30269-8. doi: 10.1016/j.nbt.2018.03.006. [Epub ahead of print]

PMID:
29635104
3.

Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease.

Zhang S, Luo J, Wu Z, Roggenbuck D, Schierack P, Reinhold D, Li J, Zeng X, Zhang F, Qian J, Li Y.

Clin Transl Gastroenterol. 2018 Feb 15;9(2):e133. doi: 10.1038/ctg.2018.1.

4.

Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).

Klehmet J, Märschenz S, Ruprecht K, Wunderlich B, Büttner T, Hiemann R, Roggenbuck D, Meisel A.

Clin Chem Lab Med. 2018 May 24;56(6):919-926. doi: 10.1515/cclm-2017-0792.

PMID:
29329103
5.

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.

Tornai T, Tornai D, Sipeki N, Tornai I, Alsulaimani R, Fechner K, Roggenbuck D, Norman GL, Veres G, Par G, Par A, Szalay F, Lakatos PL, Antal-Szalmas P, Papp M.

Sci Rep. 2018 Jan 10;8(1):399. doi: 10.1038/s41598-017-18622-1.

6.

Genotypic and Phenotypic Characteristics Associated with Biofilm Formation by Human Clinical Escherichia coli Isolates of Different Pathotypes.

Schiebel J, Böhm A, Nitschke J, Burdukiewicz M, Weinreich J, Ali A, Roggenbuck D, Rödiger S, Schierack P.

Appl Environ Microbiol. 2017 Dec 1;83(24). pii: e01660-17. doi: 10.1128/AEM.01660-17. Print 2017 Dec 15.

7.

Mobile phone radiofrequency exposure has no effect on DNA double strand breaks (DSB) in human lymphocytes.

Danese E, Lippi G, Buonocore R, Benati M, Bovo C, Bonaguri C, Salvagno GL, Brocco G, Roggenbuck D, Montagnana M.

Ann Transl Med. 2017 Jul;5(13):272. doi: 10.21037/atm.2017.04.35.

8.

Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.

Röber N, Noß L, Goihl A, Reinhold D, Jahn J, de Laffolie J, Johannes W, Flemming GM, Roggenbuck D, Conrad K, Laass MW.

Inflamm Bowel Dis. 2017 Sep;23(9):1624-1636. doi: 10.1097/MIB.0000000000001159.

PMID:
28691939
9.

Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.

Rykova E, Sizikov A, Roggenbuck D, Antonenko O, Bryzgalov L, Morozkin E, Skvortsova K, Vlassov V, Laktionov P, Kozlov V.

Arthritis Res Ther. 2017 May 2;19(1):85. doi: 10.1186/s13075-017-1295-z.

10.

Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis.

Sowa M, Trezzi B, Hiemann R, Schierack P, Grossmann K, Scholz J, Somma V, Sinico RA, Roggenbuck D, Radice A.

Medicine (Baltimore). 2016 Nov;95(44):e5225.

11.

Serological diagnosis and prognosis of severe acute pancreatitis by analysis of serum glycoprotein 2.

Roggenbuck D, Goihl A, Hanack K, Holzlöhner P, Hentschel C, Veiczi M, Schierack P, Reinhold D, Schulz HU.

Clin Chem Lab Med. 2017 May 1;55(6):854-864. doi: 10.1515/cclm-2016-0797.

12.

Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease.

Degenhardt F, Dirmeier A, Lopez R, Lang S, Kunst C, Roggenbuck D, Reinhold D, Szymczak S, Rogler G, Klebl F, Franke A, Rieder F.

Inflamm Bowel Dis. 2016 Nov;22(11):2648-2657.

13.

Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical Phenotype.

Roggenbuck D, Reinhold D, Baumgart DC, Schierack P, Conrad K, Laass MW.

Adv Clin Chem. 2016;77:77-101. doi: 10.1016/bs.acc.2016.06.002. Epub 2016 Jun 30. Review.

PMID:
27717419
14.

Impact of in Vivo High-Field-Strength and Ultra-High-Field-Strength MR Imaging on DNA Double-Strand-Break Formation in Human Lymphocytes.

Reddig A, Fatahi M, Roggenbuck D, Ricke J, Reinhold D, Speck O, Friebe B.

Radiology. 2017 Mar;282(3):782-789. doi: 10.1148/radiol.2016160794. Epub 2016 Sep 30.

PMID:
27689924
15.

Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.

Caneparo V, Pastorelli L, Pisani LF, Bruni B, Prodam F, Boldorini R, Roggenbuck D, Vecchi M, Landolfo S, Gariglio M, De Andrea M.

Inflamm Bowel Dis. 2016 Dec;22(12):2977-2987.

16.

DNA injury is acutely enhanced in response to increasing bulks of aerobic physical exercise.

Lippi G, Buonocore R, Tarperi C, Montagnana M, Festa L, Danese E, Benati M, Salvagno GL, Bonaguri C, Roggenbuck D, Schena F.

Clin Chim Acta. 2016 Sep 1;460:146-51. doi: 10.1016/j.cca.2016.06.041. Epub 2016 Jun 30.

PMID:
27374303
17.

Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.

Sowa M, Hiemann R, Schierack P, Reinhold D, Conrad K, Roggenbuck D.

Clin Rev Allergy Immunol. 2017 Aug;53(1):87-104. doi: 10.1007/s12016-016-8574-3. Review.

18.

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

Roggenbuck D, Borghi MO, Somma V, Büttner T, Schierack P, Hanack K, Grossi C, Bodio C, Macor P, von Landenberg P, Boccellato F, Mahler M, Meroni PL.

Arthritis Res Ther. 2016 May 21;18(1):111. doi: 10.1186/s13075-016-1018-x.

19.

Automated Cell-Based Quantitation of 8-OHdG Damage.

Debelec-Butuner B, Bostancı A, Heiserich L, Eberle C, Ozcan F, Aslan M, Roggenbuck D, Korkmaz KS.

Methods Mol Biol. 2016;1516:299-308. doi: 10.1007/7651_2016_344.

PMID:
27044043
20.

Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.

Martínez G, Gómez JA, Bang H, Martínez-Gamboa L, Roggenbuck D, Burmester GR, Torres B, Prada D, Feist E.

Rheumatol Int. 2016 Jun;36(6):781-91. doi: 10.1007/s00296-016-3472-9. Epub 2016 Apr 2.

Supplemental Content

Loading ...
Support Center